At present, commonly used clinical breast cancer biomarkers, such as carcinoembryonic antigen (CEA), carbohydrate antigen CA125, CA153 and so on, lack sensitivity and specificity for the diagnosis of breast cancer [74]. Here, CEACAM5 is linked to breast cancer.